Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED
- PMID: 38004570
- PMCID: PMC10674215
- DOI: 10.3390/pharmaceutics15112591
Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED
Abstract
Dry eye disease (DED) is a multifactorial disorder in which tear fluid homeostasis is lost, resulting in increased tear film osmolarity and ocular surface irritation. In Asia, the short tear film breakup time-type DED, which has become a global problem in recent years, is common. While the mainstay of DED treatment in the West is the suppression of inflammation, the first goal of treatment is the stabilization of the tear film in Asia. To date, artificial tears and steroid eye drops have been the main treatment for DED. However, artificial tears require frequent administration of eye drops and thus pose adherence problems, while steroids have problems with side-effects (cataracts, increased intraocular pressure). This review evaluates the new generation therapies in Asia based on what is known about them and demonstrates that they are more effective for DED than traditional therapies such as artificial tears and steroids. Based on considerations, it is proposed that the optimal treatment for the short tear film breakup time-type DED is the initial application of mucin-secretion-enhancing eye drops (long-acting diquafosol) and oral supplements; and if additional treatment is needed, cyclosporine eye drops and the adjunctive therapies presented in this review are added.
Keywords: contact lens; cyclosporine; diquafosol; dry eye; dry eye disease (DED); dry eye syndrome; meibomian gland dysfunction; serum; supplement; tear film.
Conflict of interest statement
The author declares no conflict of interest.
Similar articles
-
Dry Eye Syndrome.2024 Feb 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Feb 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29262012 Free Books & Documents.
-
Management Strategies for Evaporative Dry Eye Disease and Future Perspective.Curr Eye Res. 2022 Jun;47(6):813-823. doi: 10.1080/02713683.2022.2039205. Epub 2022 May 6. Curr Eye Res. 2022. PMID: 35521685 Review.
-
Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial.Ocul Surf. 2021 Apr;20:62-69. doi: 10.1016/j.jtos.2020.12.006. Epub 2021 Jan 2. Ocul Surf. 2021. PMID: 33401019 Clinical Trial.
-
Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies.Clin Ophthalmol. 2023 Dec 13;17:3883-3898. doi: 10.2147/OPTH.S428725. eCollection 2023. Clin Ophthalmol. 2023. PMID: 38105908 Free PMC article. Review.
-
Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.J Ocul Pharmacol Ther. 2022 Mar;38(2):133-140. doi: 10.1089/jop.2021.0083. Epub 2022 Jan 19. J Ocul Pharmacol Ther. 2022. PMID: 35049373 Clinical Trial.
Cited by
-
Short-Term Changes in Tear Film Stability and Tear Volume Following the Application of Various DED Management Options in a Healthy Young Population.J Pers Med. 2025 Apr 27;15(5):173. doi: 10.3390/jpm15050173. J Pers Med. 2025. PMID: 40423045 Free PMC article.
-
Safety and efficacy of rebamipide compared to artificial tears for the treatment of dry eye: a systematic review and meta-analysis.BMC Ophthalmol. 2025 May 27;25(1):317. doi: 10.1186/s12886-025-04146-0. BMC Ophthalmol. 2025. PMID: 40426110 Free PMC article.
-
Vectored Thermal Pulsation as a Treatment for Meibomian Gland Dysfunction: A Review Spanning 15 Years.Ophthalmol Ther. 2024 Aug;13(8):2083-2123. doi: 10.1007/s40123-024-00976-1. Epub 2024 Jun 15. Ophthalmol Ther. 2024. PMID: 38879718 Free PMC article. Review.
-
Management of Dry Eye Disease for Intraocular Lens Power Calculation in Cataract Surgery: A Systematic Review.Bioengineering (Basel). 2024 Jun 11;11(6):597. doi: 10.3390/bioengineering11060597. Bioengineering (Basel). 2024. PMID: 38927833 Free PMC article. Review.
References
-
- Tangmonkongvoragul C., Chokesuwattanaskul S., Khankaeo C., Punyasevee R., Nakkara L., Moolsan S., Unruan O. Prevalence of symptomatic dry eye disease with associated risk factors among medical students at Chiang Mai University due to increased screen time and stress during COVID-19 pandemic. PLoS ONE. 2022;17:e0265733. doi: 10.1371/journal.pone.0265733. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical